Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Reanalysis of a proteome-wide level study with MaxLynx

ABSTRACT: Reanalysis of the publicly available proteome-wide level dataset with DSBU from Goetze et al., Anal Chem. 2019 (PXD012546).

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Sule Yilmaz

LAB HEAD: Juergen Cox

PROVIDER: PXD027188 | Pride | 2022-01-11

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ID.fasta	Fasta
	R1_A10.raw	Raw
	R1_A11.raw	Raw
	R1_A12.raw	Raw
	R1_A4.raw	Raw

Items per page:

1 - 5 of 71

Similar Datasets

Reanalysis of a synthetic cross-linked peptide library with MaxLynx

Project description:Reanalysis of a synthetic crosslinked peptide library datasets with DSS (non-cleavable), DSSO and DSBU (MS-cleavable) cross linkers from Beveridge et al., Nat. Commun., 2020 (PXD014337)

2022-01-11 | PXD027159 | Pride

Reanalysis of publicly available medium size protein complex data set with MaxLynx

Project description:Reanalysis of the publicly available medium size protein complex data set by Kokic and co-workers, Nat Commun. 2019 (PXD013947)

2022-01-11 | PXD030578 | Pride

S. islandicus REY15A pH/Temp stress

Project description:diDO-IPTL quantitative analysis (Waldbauer et al. 2017 Anal. Chem.) of pH- and temperature-stress during mid-log and early-stationary phase growth of S. islandicus REY15A

2022-10-21 | MSV000090562 | MassIVE

Middle Island Sinkhole Microbial Mat - Seasonality

Project description:Samples from benthic phototrophic microbial mats of Middle Island Sinkhole, Lake Huron, MI, USA. Peptides labeled in vitro for quantitative analysis by diDO-IPTL (Waldbauer et al. 2017 Anal. Chem.).

2022-01-20 | MSV000088706 | MassIVE

S isotope fractionation and energy availability in D. vulgaris

Project description:Quantitative proteomics data on Desulfovibrio vulgaris DSM644 grown in lactate-limited chemostats at 3 different rates, exhibiting different magnitudes of S isotope fractionation during dissimilatory sulfate reduction. Protein quantitation by diDO-IPTL peptide isotope labeling (Waldbauer et al. 2017 Anal. Chem.)

2021-07-22 | MSV000087869 | MassIVE

Mimicked synthetic ribosomal protein complex for benchmarking cross-linking mass spectrometry workflows

Project description:The field of cross-linking mass spectrometry has matured to a frequently used tool for the investiga-tion of protein structures as well as interactome studies up to a system wide level. The growing com-munity generated a broad spectrum of applications, linker types, acquisition strategies and specialized data analysis tools, which makes it challenging, especially for newcomers, to decide for an appropriate analysis workflow. Therefore, we here present a large and flexible synthetic peptide library as reliable instrument to benchmark cross-linkers with different reactive sites as well as acquisition techniques and data analysis algorithms. Additionally, we provide a tool, IMP-X-FDR, that calculates the real FDR, compares results across search engine platforms and analyses crosslink properties in an auto-mated manner. The library was used with the reagents DSSO, DSBU, CDI, ADH, DHSO and azide-a-DSBSO and data were analysed using the algorithms MeroX, MS Annika, XlinkX, pLink and Max-Lynx. We thereby show that the correct algorithm and search setting choice is highly important to im-prove ID rate and FDR in combination with software and sample-complexity specific score cut-offs. When analysing DSSO data with MS Annika, we reach high identification rates of up to ~70 % of the theoretical maximum (i.e. 700 unique lysine-lysine cross-links) while maintaining a low real FDR of < 3 % at cross-link level and with extraordinary high reproducibility, representatively showing that our test system delivers valuable and statistically solid results.

2022-05-24 | PXD029252 | Pride

Analysis of colorectal adenocarcinoma tissue samples by DESI mass spectrometry imaging

Project description:Ex vivo colorectal adenocarcinoma samples were analysed by desorption electrospray ionisation using an Orbitrap mass spectrometer. The samples were analysed in negative mode over the m/z range 600-1000. Some of the samples presented in this dataset were analysed as part of [1]. The study makes available imzML files of profile and centroid mode data, as well as low- and high- resolution optical image files of H&E-stained sections. These files can be found in the zip file named after each tissue section. </p> Ref:</br> [1] Gerbig S, Golf O, Balog J, Denes J, Baranyai Z, Zarand A, Raso E, Timar J, Takats Z. Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging. Anal Bioanal Chem. 2012 Jun;403(8):2315-25. doi:10.1007/s00216-012-5841-x. PMID:22447214</br>

2016-04-28 | MTBLS289 | MetaboLights

Microbiome biomarkers for Improved Screening of Anal Cance

Project description:Anal cancer is a leading neoplasia in people with immune impartments populations, and the lack of an accurate screening test challenges its prevention. Because the bacteria living in the anal epithelium the anal microbiota seems to influence and be influenced by cancer development, specific patterns of anal microbes could help in the diagnosis of precancerous anal lesions. We aimed to discover microbial biomarkers of anal precancer in high-risk populations. We discovered 12 proteins, previously reported to be associated with cancer progression, that were more abundant in the anal bacterial from subjects with precancerous lesions.

2022-12-11 | PXD037268 | Pride

Komagataella_phaffii_lipids_C30

Project description:LC-MS/MS lipidomics data of Komagataella phaffii recorded on a Q Exactive HF with apex trigger in positive ion mode. Thermo Scientific Accucore C30 column (150 x 2.1 mm, 2.6 um) reverse phase column: A: ACN:H2O 6:4, 10 mM NH4Form, 0.1% FA, B: IPA:ACN 9:1, 10 mM NH4Form, 0.1% FA, 27 min gradient, follows Anal. Chem. 2018, 90 (11), 6494-6501.

2022-07-28 | MSV000090008 | MassIVE

Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions

Project description:Anal squamous cell carcinoma (ASCC) is a rare gastrointestinal malignancy that is linked to high-risk Human papillomavirus (HPV) infection. It is often preceded by precursor lesions like Low-Grade Squamous Intraepithelial Lesions (LGSIL) and High-Grade Squamous Intraepithelial Lesions (HGSIL). The incidence of ASCC varies across populations, with heightened risk in HIV-positive individuals. In a previous study, we characterized the anal microbiome in high-risk HIV-exposed MSM and TGW subjects. We revealed oncogenic viromes and pertinent bacterial species associated with anal SILs. Our current investigation aimed to delineate transcriptomic and metatranscriptomic changes during the progression from precancerous lesions to ASCC. We collected 70 anal tissue samples across various lesion stages (LGSIL, HGSIL, and ASCC). Our metatranscriptomic analysis revealed that Fusobacterium nucleatum, F. gonidiaformans, Bacteroides fragilis, Campylobacter ureolyticus, and Cribacterium bergeronii were more prevalent in ASCC than in precancerous lesions. These bacterial species contributed with gene encoding enzymes (e.g.: Acca, glyQ, eno, pgk and por) and oncoproteins (FadA and dnaK) revealing potential new markers for diagnosis or treatment approaches. Our unsupervised transcriptome analysis identified two distinct sample clusters based on histological diagnosis, immune infiltrate, HIV and HPV status, and pathway activities such as immune activation, cell cycle, and antiviral signaling that recapitulate the natural history of anal cancer progression. Mutations were observed affecting KMT2C (30%), PIK3CA (21%), EP300 (21%) and NOTCH1 (13%) cancer driver genes among ASCC but also in precancerous lesions. Our study provides insights into the molecular mechanisms governing anal cancer progression, offering valuable information that may help to stratify HGSIL cases with low- or high-risk progression to the malignant stages.

2024-08-04 | GSE253560 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data